STUDY IDENTIFIES NEW NUTRIENT-BASED MECHANISM OF CANCER PROLIFERATION, DRUG RESISTANCE.

Cancer researchers have known for years that tumours have unusual metabolisms, their rapid use of glucose is used as a diagnostic tool for tumours in PET scans.  However, only recently have scientists begun to flesh out the details of this metabolic shift.  Now, a new study from researchers at the Ludwig Cancer Research and University of California, San...

Read More

DECADES OLD MYSTERY SOLVED AS RESEARCHERS MAP THE EFFECT OF T2 DIABETES ON THE LYMPHATIC VESSELS.

Approximately 28 million Americans live with Type 2 diabetes, a condition characterized by high blood sugar levels.  The immune system plays a part in type 2 diabetes. Researchers have linked insulin resistance to high levels of cytokines, which are released in response to inflammation in the body.  The immune system’s response to inflammation leads to fat cells...

Read More

RESEARCHERS HAVE VISUALISED CHANGES MADE TO RNA IN THE BRAIN BY ADMINISTERED DRUGS.

A group of researchers from Kyoto University have successfully visualized RNA behaviour and its response to drugs within the living tissue brain of live mice by labeling specific RNA molecules with fluorescent probes. The team state that their study can potentially lead to faster, and more accurate screening processes for the discovery and development of new drugs. ...

Read More

Engineered particles ‘may become antibiotics of the future’

There is a pressing need for new approaches to fight harmful bacteria as the global threat of rising drug resistance appears set to outpace the rate at which we can produce new antibiotics to fight deadly infections like tuberculosis. Now, researchers in the field of synthetic biology have addressed this challenge in a different way. They have engineered particles called...

Read More

Experimental drug that may repair nerve damage in MS moves forward

A new study suggests that an investigational drug for multiple sclerosis (MS) may repair myelin according to a study that will be presented at the American Academy of Neurology’s 67th Annual Meeting in Washington, DC, April 18 to 25, 2015. “This study, for the first time, provides biological evidence of repair of damaged myelin in the human brain, and advances the field...

Read More

Cancer patients treated in world-first clinical trial of Canadian viral therapy

Canadian researchers have launched the world’s first clinical trial of a novel investigational therapy that uses a combination of two viruses to attack and kill cancer cells, and stimulate an anti-cancer immune response. Previous research by this team and others worldwide suggests that this approach could be very powerful, and could have fewer side effects than conventional...

Read More